Adaptive HF Voltage Control for Tissue Coagulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current electrical tissue coagulation methods are inefficient in achieving high-quality, reproducible results within the shortest time frame, often leading to premature tissue desiccation and adherence to electrodes due to the lack of real-time resistance monitoring and adaptive energy input.
Innovation Solution
The method involves applying a high-frequency voltage to biological tissue without a preceding measurement phase, continuously monitoring tissue resistance, and regulating the voltage to maintain a desired energy input, preventing excessive tissue resistance and ensuring controlled coagulation without premature desiccation, allowing for larger coagulation volumes and precise energy management.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of time
If a constant HF voltage is applied to initiate coagulation without a preceding measurement phase, then the coagulation process starts immediately without time loss, but the tissue resistance may rise excessively leading to premature desiccation and adherence to electrodes
Solution Approach 1:
The patent implements continuous monitoring of tissue resistance during HF voltage application and uses this feedback to dynamically regulate the voltage. When tissue resistance rises excessively, the system automatically reduces the HF voltage to prevent premature desiccation and adherence, while still maintaining coagulation effectiveness. This closed-loop control eliminates the need for a preliminary measurement phase while preventing tissue damage.
Solution Approach 2:
The patent transitions from static constant voltage application to dynamic voltage regulation based on real-time tissue resistance monitoring. The HF voltage is continuously adjusted according to the tissue's electrical characteristics, allowing the system to adapt to changing tissue conditions during coagulation and prevent desiccation while maintaining treatment effectiveness.
2Productivity
If high energy input is applied to achieve large coagulation volumes, then coagulation speed increases, but tissue desiccation and adherence to electrodes occur
Solution Approach 1:
The system continuously monitors tissue resistance and uses this information to regulate HF voltage in real-time. When resistance indicates approaching desiccation thresholds, the voltage is automatically reduced to prevent harmful effects while maintaining sufficient energy input for effective coagulation. This feedback mechanism enables high productivity without tissue damage.
Solution Approach 2:
The patent dynamically changes the HF voltage parameter based on real-time tissue resistance measurements. By adjusting voltage levels according to the tissue's electrical characteristics and coagulation progress, the system optimizes energy input to achieve large coagulation volumes while preventing desiccation and other harmful effects.
3Speed
If HF voltage is increased to accelerate coagulation, then treatment time decreases, but sparks and plasma generation occur causing rapid tissue desiccation
Solution Approach 1:
The system monitors tissue resistance and uses this feedback to prevent voltage levels that would generate sparks and plasma. By continuously adjusting HF voltage based on real-time tissue conditions, the system maintains coagulation effectiveness while preventing harmful electrical discharge and associated tissue desiccation.
Solution Approach 2:
The patent replaces mechanical voltage control with electrical feedback control based on tissue resistance monitoring. This substitution allows precise control of energy input at the tissue interface, preventing sparks and plasma generation while maintaining efficient coagulation through optimized electrical parameter regulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables high-quality, rapid coagulation with reliable prevention of tissue desiccation and adherence, achieving reproducible results by maintaining tissue resistance within safe limits and allowing for larger tissue volumes to be coagulated while limiting energy input to prevent overheating.
Implementation Method 1
High-frequency (HF) electric current is used for coagulation. The variation in electrical tissue resistance is monitored during the application of the specific HF voltage.
Implementation Method 2
The variation in electrical tissue resistance is monitored during the application of the specific HF voltage.
Data Source
AI summary
Maximum HF current is initially introduced into tissue at a pre-specified maximum coagulation voltage. In this initial state, the tissue behaves in accordance with Ohm's law and can take up the maximum energy per unit of time. After the tissue has changed from an initial state to a state in which the tissue impedance or resistance is voltage-dependent, the HF parameters are selected such that the maximum possible energy input per unit of time is set.